Emerging Trends in Personalised Medicine at PHARMAP 2026
As public expectations for healthcare equality rise, pharmaceutical companies are shifting toward more inclusive manufacturing and packaging models. Designing for all – regardless of individual characteristics – is no longer optional. PHARMAP 2026 addresses this transformation with a specialised session on patient-friendly design and its role in modern medicine. The event is scheduled for 20-21 April in Amsterdam.
Trust and engagement are now at the forefront, with 90% of health systems ranking patient experience as a top priority. This shift has turned patient-centric medicine into a data-driven, operational reality. By integrating patient input from the pre-clinical stage, pharmaceutical companies are redefining the design and evaluation of modern medicine.
Bayer AG is changing clinical research through its ALYCE platform, utilising AI and data lakehouses to power decentralised trials that prioritise patient convenience. However, these digital solutions are not the final point in the company’s evolution. Instead, they represent only one facet of a broader strategy. At PHARMAP 2026, Robin Falter, Value Stream Lead at Bayer, demonstrates how this vision is applied to physical products and shares his expertise on patient-centric packaging.
The session also features Karel van der Waarde from HSLU, an institution pioneering research in personalised medicine. A prime example of this work is HSLU’s Interdisciplinary Network (IDN) Health, established in 2024 to unite its six schools in creating sustainable healthcare solutions. The network is already advancing more than 50 collaborative research and publication initiatives, providing direct context for van der Waarde’s insights on optimising medical information for patient and carer use.
Understanding the patient’s perspective on packaging and information is more essential than ever in today’s high-demand market. Joining the session, Joost Groen, Independent Consultant for Patient Empowerment at Sidewise, provides strategic insights into how packaging can be optimised to serve the patient’s needs.
Patient-centricity is the future, and with the right insights, the industry is poised for a significant leap forward. PHARMAP 2026 facilitates high-level dialogue on the technologies shaping this transition.
Explore the business programme at https://sh.bgs.group/3u6 and take a place on stage alongside experts from Bayer AG, HSLU, and Sidewise.
